1/85
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai |
|---|
No study sessions yet.
which types of SSTIs are typically associated with purulence?
folliculitis, furuncles
carbuncles
± impetigo
abscess
± diabetic foot infection
± human or animal bites
which types of SSTIs are not typically associated with purulence?
erysipelas
cellulitis
necrotizing fasciitis
which two gram-positive organisms are typically associated with SSTIs?
Streptococcus spp. and Staphylococcus spp.
which gram-positive organism is typically associated with purulence?
Staphylococcus spp.
an infection with which organism classically presents as "streaking, nonpurulent cellulitis"?
Streptococcus spp
mild SSTI
description:
treatment:
P: I&D
NP: oral abx
moderate SSTI
description:
systemic signs of infection
treatment:
P: I&D + oral abx
NP: IV abx
severe SSTI
description:
P: failed I&D + oral abx OR systemic signs of infection OR immunocompromised patients
NP: failed oral abx OR systemic signs of infection OR immunocompromised patients OR clinical signs of deeper infection OR evidence of organ dysfunction
treatment:
P: I&D + IV abx
NP: IV abx (broad-spectrum)
mild diabetic food infection
description:
local infection (involves only the skin and subcutaneous tissue) AND no systemic signs; if erythema present must be > 0.5 cm to ≤ 2 cm around the ulcer
treatment:
oral abx
probable pathogens: Staphylococcus aureus, Streptococcus spp.
moderate diabetic food infection
description:
no systemic signs AND local infection + erythema > 2 cm OR involvement of deeper structures
treatment:
oral OR IV abx
probable pathogens: polymicrobial**
severe diabetic food infection
description:
local infection AND ≥ 2 signs of SIRS*
treatment:
oral OR IV abx
probable pathogens: polymicrobial**
what are the MRSA risk factors for SSTIs?
-purulence
-history of previous MRSA infection
-high local prevalence of MRSA
-use of antibiotics in last month
-hospitalization in the past year
-history or previous MRSA colonization
-MRSA nares swab
what are the Psuedomonas risk factors for SSTIs?
-warm climate
-frequent exposure of foot to water
-high prevalence of Pseudomonas
-severe infection
true or false: Cephalosporins should always be avoided in the setting of a penicillin allergy.
false
in assessing susceptibility patterns in an antibiogram, what percentage cutoff would warrant AVOIDANCE of
that antibiotic for empiric coverage?
80
are there renal dose adjustments for dicloxacillin, nafcillin, and oxacillin?
no
what do penicillin G and penicillin VK have a DDI against?
probenecid
should you use higher or lower doses if piperacillin-tazobactam for more severe infections?
higher
does piperacillin-tazobactam have Pseudomonas coverage?
yes
cefepime adverse effect
neurotoxicity
does ceftriaxone need renal dose adjustments?
no
tedizolid adverse effect
myelosuppression, peripheral neuropathy, serotonin syndrome, thrombocytopenia
common adverse effect of the tetracyclines
photosensitivity
DDI with the tetracyclines
oral cations
do doxycline or omadacycline need renal dose adjustment?
no
adverse effects of the oxazolidinones
myelosuppression, peripheral neuropathy, serotonin syndrome, thrombocytopenia
do the oxazolidinones need renal dose adjustment?
no
DDI of the oxazolidinones
serotonergic agents
adverse effect of dalbavancin and oritavancin
infusion reaction
DDI of oritavancin
warfarin, heparin, coagulation tests
adverse effect of telavancin
foamy urine, nephrotoxicity, infusion-related reaction, taste disturbance,
DDI of telavancin
heparin, coagulation tests
adverse effect of vancomycin
nephrotoxicity, infusion-related reaction
DDI of vancomycin
nephrotoxic agents
adverse effects of fluoroquinolones
CNS effects, peripheral neuropathy, photosensitivity, QT prolongation, tendinitis, tendon rupture
DDI of fluoroquinolones
oral cations
which fluoroquinolone does not have an adverse effect of QT prolongation or photosensitivity?
delafloxacin
does moxifloxacin need renal dose adjustment?
no
adverse effect of clindamycin
C.diff diarrhea
does clindamycin need renal dose adjustment?
no
adverse effect of daptomycin
increased creatinine phosphokinase, eosinophilic pneumonia
does daptomycin need higher or lower doses for more severe infections (bacteremia, osteomyelitis, vancomycin-resistant)?
higher
DDI of daptomycin
statins
adverse effect of metronidazole
metallic taste, peripheral neuropathy
what should you avoid taking metronidazole with?
alcohol
DDI of metronidazole
warfarin
adverse effect of mupirocin
skin irritation
adverse effects of trimethoprim-sulfamethoxazole
bone marrow suppression, increased potassium, increased serum creatinine
should you use higher or lower doses of trimethoprim-sulfamethoxazole for diabetic foot infections?
higher
DDI for trimethoprim-sulfamethoxazole
warfarin, renin-angiotensin-aldosterone system inhibitors
which organism should be empirically treated for with the presence of purulence in the setting of an SSTI?
MRSA
which organisms should be empirically treated for with the absence of purulence in the setting of an SSTI?
MSSA, Streptococcus spp., and gram negative bacilli
when can NO antibiotics potentially be a treatment option for SSTIs?
in mild purulent infections
when are oral antibiotics for SSTI treatment recommended?
SSTI
mild non-purulent infections
moderate purulent infections
diabetic foot infections
mild diabetic foot infections
moderate diabetic foot infections
severe diabetic foot infections
when are intravenous antibiotics for SSTI treatment
recommended?
SSTI
moderate non-purulent infections
severe purulent and non-purulent infections
diabetic foot infections
moderate diabetic foot infections
severe diabetic foot infections
which antibiotics commonly used for the treatment of SSTIs come in an oral formulation?
amoxicillin-clavulanate
dicloxacillin
penicillin VK
cefuroxime
cephalexin
doxycyline
minocycline
omadacycline
linezolid
tedizolid
ciprofloxacin
delafloxacin
levofloxacin
moxifloxacin
clindamycin
metronidazole
trimethoprim-sulfamethoxazole
which antibiotics commonly used for the treatment of SSTIs come in an intravenous formulation?
ampicillin-sulbactam
nafcillin
oxacillin
penicillin VK
penicillin G
piperacillin-tazobactam
cefazolin
cefepime
cefoxitin
ceftraoline
ceftazidime
ceftriaxone
doripenem
ertapenem
imipenem-cilastatin
meropenem
doxycyline
minocycline
omadacycline
linezolid
tedizolid
oritavancin
telavancin
vancomycin
ciprofloxacin
delafloxacin
levofloxacin
moxifloxacin
aztreonam
clindamycin
daptomycin
metronidazole
trimethoprim/sulfamethoxazole
which antibiotics commonly used for the treatment of SSTIs cover MRSA?
clindamycin PO
doxycycline
TMP-SMX
ceftraoline
dalbavancin
daptomycin
linezolid
oritavancin
tedizolid
vancomycin
which antibiotics commonly used for the treatment of SSTIs cover Pseudomonas?
aztreonam
carbapenem
cefepime
ciprofloxacin
levofloxacin
piperacillin-tazobactam
which antibiotics commonly used for the treatment of SSTIs cover anaerobes?
ampicillin-sulbactam
clindamycin
piperacillin-tazobactam
metronidazole
what is the place in therapy of dalbavancin, oritavancin?
one time infusion
what is the place in therapy of delafloxacin?
-broad coverage (MRSA, P. aeruginosa)
-no known QT prolongation or phototoxicity
what is the place in therapy of omadacycline?
activity against tetracycline-resistant pathogens
what is the place in therapy of tedizolid?
-less frequent dosing
-less risk of serotonin syndome
-less potential for thrombocytopenia compared with linezolid
when would a patient be "eligible" to switch from an intravenous antibiotic to an oral antibiotic?
-intravenous antibiotics > 24 hours
-stable infection
-clinical improvement
-afebrile
-WBC trending down
-hemodynamically stable
-ability to tolerate oral
-bacteria susceptibility to oral treatment
how long should a SSTI typically be treated?
SSTI
individualized to patient response, but typically 5 to 14 days
diabetic foot infection
1 to 4 weeks
organism that causes streaking, nonpurulent cellulitis
streptococcus spp.
organism that causes purulence and erythema
staphylococcus spp.
organism that causes pain out of proportion to exam
necrotizing facitis
comorbidities of SSTIs
-diabetes
-peripheral artery disease
-poor nutritional status
-concomitant osteomyelitis
treatment for mild purulent SSTIs
empiric MRSA coverage
no antibiotics
treatment for moderate purulent SSTIs
empiric MRSA coverage
clindamycin PO
doxycycline
tmp-smx
treatment for severe purulent SSTIs
empiric MRSA coverage
ceftraoline
dalbavancin
daptomycin
linezolid
oritavancin
tedizolid
vanocmycin
treatment for mild non-purulent SSTIs with no MRSA risk factors (empiric MSSA, sttreptococcus spp., empiric GMB coverage)
cephalexin
clindamycin PO
dicloxacillin
penicillin VK
treatment for moderate non-purulent SSTIs with no MRSA risk factors (empiric MSSA, sttreptococcus spp., empiric GMB coverage)
cefazolin
ceftriaxone
clindamycin IV
penicillin
treatment for severe non-purulent SSTIs with no MRSA risk factors (empiric MSSA, sttreptococcus spp., empiric GMB coverage)
vancomycin AND piperacillin-tazobactam
imipenem-cilastatin
meropenem
treatment for mild non-purulent SSTIs with MRSA risk factors (empiric MSSA, sttreptococcus spp., empiric GMB coverage)
doxycycline
tmp-smx
AND
penicillin
amoxicillin
cephalexin
treatment for moderate non-purulent SSTIs with MRSA risk factors (empiric MSSA, sttreptococcus spp., empiric GMB coverage)
ceftraoline
dalbavancin
daptomycin
linezolid
oritavancin
tedizolid
vancomycin
treatment for severe non-purulent SSTIs with MRSA risk factors (empiric MSSA, sttreptococcus spp., empiric GMB coverage)
vancomycin
AND
piperacillin-tazobactam
imipenem-cilastatin
meropenem
treatment for mild foot infections based on Staphylococcus spp., Streptococcus infections
amoxicillin-clavulanate
cephalexin
clindamycin
dicloxacillin
levofloxacin
moxifloxacin
treatment for moderate/severe diabetic foot infections based on susceptible MSSA, Streptococcus spp., and Enterobacteriaceae infections
ampicillin-sulbactam
cefoxitin
ertapenem
imipenem-cilastatin
levofloxacin
moxifloxacin
treatment for moderate/severe diabetic foot infections based on susceptible MRSA infections
daptomycin
linezolid
vancomycin
treatment for moderate/severe diabetic foot infections based on anaerobes infections
ampicillin-sulbactam
clindamycin
piperacillin-tazobactam
metronidazole
treatment for moderate/severe diabetic foot infections based on Pseudomonas infections
aztreonam
carbapenem
cefepime
ciprofloxacin
levofloxacin
piperacillin-tazobactam
treatment for human or animal bites via *empiric Staphylococcus spp.; Streptococcus spp.; Pasteurella multocida (cat or dog bites); Eikenella corrodens (human bites); anaerobic coverage"
amoxicillin-clavulante
doxycycline
moxifloxacin
when do incision and drainage function need antibiotic therapy?
if:
-inability to drain completely
-lack of response
-associated septic phlebitis
-severe or extensive disease
-systemic illness
-extremes of age
-associated comorbidities or immunosuppression